BIOMAT Database Logo BIOMAT Database Logo

Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study. 1992

S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
Department of Pathology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

Epidermal growth factor receptor (EGF-R) was studied with monoclonal antibody 2E9 on 50 ovarian tumors of various histological types and 10 non-tumorous ovarian tissues by immunohistochemistry. Enhanced expression was observed in 26/50 (52%) of the tumors. Only 25 out of 46 epithelial tumors (54%) showed positivity in epithelial tumor cells. Staining was cytoplasmic in all cases. No correlation was established between EGF-R expression and the histological type of the epithelial tumor. Apart from EGF-R expression in tumor cells, low immunoreactivity was also observed in stromal and endothelial cells in both normal and tumorous ovarian tissues. Furthermore in 8/9 specimens containing necrotic areas, EGF-R was noticed in these areas as well. Both of the latter observations may have impact on the evaluation of the prognostic value of EGF-R activity in tumors, when based on EGF-R measurements using biochemical binding studies. We therefore recommend that EGF-R is measured with both methods in studies regarding its clinical value.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D002288 Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) Carcinoma, Colloid,Carcinoma, Mucinous,Adenocarcinomas, Mucinous,Carcinomas, Colloid,Carcinomas, Mucinous,Colloid Carcinoma,Colloid Carcinomas,Mucinous Adenocarcinoma,Mucinous Adenocarcinomas,Mucinous Carcinoma,Mucinous Carcinomas
D003536 Cystadenocarcinoma A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed) Cystadenocarcinomas
D003537 Cystadenoma A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed) Cystadenomas
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D004848 Epithelium The layers of EPITHELIAL CELLS which cover the inner and outer surfaces of the cutaneous, mucus, and serous tissues and glands of the body. Mesothelium,Epithelial Tissue,Mesothelial Tissue,Epithelial Tissues,Mesothelial Tissues,Tissue, Epithelial,Tissue, Mesothelial,Tissues, Epithelial,Tissues, Mesothelial
D005260 Female Females

Related Publications

S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
Immunohistochemical demonstration of epidermal growth-factor receptors in normal, benign and malignant thyroid tissues.
August 1992, International journal of oncology,
S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
[Immunohistochemical analysis of epidermal growth factor receptors expression in malignant ovarian tumors].
January 2005, Akusherstvo i ginekologiia,
S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
[Expression of epidermal growth factor receptors in benign ovarian tumors].
January 2004, Akusherstvo i ginekologiia,
S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
[Epidermal growth factor receptors in malignant and benign tumors in children].
January 2000, Vestnik Rossiiskoi akademii meditsinskikh nauk,
S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
Immunohistochemical demonstration of epidermal growth factor and c-myc oncogene product in normal, benign and malignant thyroid tissues.
January 1991, Histopathology,
S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors.
June 2008, Clinical cancer research : an official journal of the American Association for Cancer Research,
S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
Epidermal growth-factor receptor expression in malignant ovary, benign ovarian-tumors and normal ovary - a comparison.
February 1993, International journal of oncology,
S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
Epidermal growth factor receptor in normal ovaries and benign ovarian tumours.
December 1992, European journal of obstetrics, gynecology, and reproductive biology,
S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
Organization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical study.
September 1993, Cancer,
S C Henzen-Logmans, and M E van der Burg, and J A Foekens, and P M Berns, and R Brussée, and J H Fieret, and J G Klijn, and S Chadha, and C J Rodenburg
Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.
July 2008, International journal of oncology,
Copied contents to your clipboard!